Avenda Health Brings AI Prostate Cancer Mapping to Arizona

Irvine, California, U.S., September 18, 2026

Avenda Health Expands AI Mapping in Arizona

The new collaboration brings Unfold AI, Avenda Health’s proprietary artificial intelligence platform, to Arizona Urology Specialists. The technology is designed to analyze patient-specific clinical information and prostate imaging to generate a three-dimensional map that estimates the location and extent of clinically significant prostate cancer within the prostate. Avenda Health developed Unfold AI to help physicians visualize prostate cancer more precisely during treatment planning. The platform combines information from MRI scans, biopsy results, and other clinical data to produce a personalized representation of suspected cancerous tissue. Physicians can use this information alongside their clinical judgment when determining an appropriate treatment strategy.

The Arizona expansion is particularly relevant to the increasing use of focal therapy, an approach that targets cancerous tissue while attempting to preserve more of the surrounding healthy prostate tissue. By providing physicians with an AI-generated cancer map, the technology is intended to support treatment planning that is tailored to the individual patient’s disease characteristics.

AI Technology Supports Personalized Prostate Treatment

Prostate cancer mapping is an important component of focal therapy because physicians need to understand where clinically significant cancer is located before determining the treatment area. Traditional diagnostic information can include MRI imaging and biopsy findings, but the interpretation and integration of these data can be complex. Unfold AI is designed to provide an additional layer of computational analysis. The platform uses artificial intelligence and machine learning to integrate available patient information and estimate the probability and location of clinically significant prostate cancer. The resulting map can provide physicians with a visual representation of the suspected disease distribution.

Avenda Health has positioned the technology as a tool intended to support, rather than replace, physician decision-making. The company’s approach is focused on combining AI-generated insights with urologist expertise to develop individualized treatment plans. The expansion to Arizona also reflects the broader adoption of AI-based technologies in urology and oncology. As healthcare providers increasingly incorporate artificial intelligence into diagnostic and treatment workflows, technologies capable of integrating imaging and clinical data may provide additional tools for physicians managing complex diseases.

Arizona Urology Specialists Adds AI-Assisted Care

Through the collaboration, Arizona Urology Specialists will provide access to the technology for appropriate patients undergoing evaluation and treatment planning for prostate cancer. The organization represents another urology practice incorporating AI-supported mapping into its clinical workflow. For patients considering focal therapy, accurate identification of the cancer’s location and extent is an important part of determining whether the approach is appropriate. AI-assisted mapping may help clinicians evaluate this information more systematically while developing patient-specific treatment strategies.

Avenda Health’s expansion into Arizona follows the company’s broader efforts to increase access to AI-enabled prostate cancer care. The company has been developing Unfold AI as part of a strategy focused on improving the precision of prostate cancer treatment and supporting physicians with advanced computational tools. The Arizona launch also highlights the growing intersection between artificial intelligence, medical imaging, and personalized oncology. As AI platforms continue to be evaluated and adopted in clinical settings, their ability to integrate multiple sources of patient information could become increasingly relevant to treatment planning.With the addition of Arizona Urology Specialists, Avenda Health is expanding the clinical reach of its Unfold AI prostate cancer mapping platform. The collaboration provides another opportunity for urologists to incorporate AI-assisted disease mapping into prostate cancer treatment planning while maintaining physician oversight. The development represents a continued expansion of AI applications in urology and the use of technology to support more individualized approaches to prostate cancer care.

Source: Avenda Health press release